With the Supreme Court decision and the FDA user fee reauthorization behind us, companies now have more certainty and new questions about regulatory and reimbursement pathways to securing value-based payment for innovative medical devices.
Arent Fox Senior Health Care Advisor Ed Dougherty presents an audio CD/Transcript of the webinar sponsored by FDAnews on securing value-based payment for medical devices in the current environment.
The audio CD/Transcript addresses best practices and recommend strategies for successful reimbursement planning for medical devices and diagnostics in the US. The discussion draws together policy and tactics to create a “roadmap” for securing regulatory and reimbursement success.
In today’s rapidly changing times, a step-wise, multi-modal approach is needed to survive. This audio CD/Transcript discusses:
The audio CD/Transcript also identifies three recent policy developments most likely to impact success in securing payment for value of medical devices and diagnostics.
To guide you down this confusing road, FDAnews has called on one of the industry’s top medical device reimbursement experts, Arent Fox’s Senior Healthcare Advisor Ed Dougherty.
In just 90 minutes, you’ll dig deep into the finer points of device reimbursement strategies and how to prepare for the changes ahead.Order now
Here’s a suggested list of potential participants from your organization:
Ed Dougherty, Senior Healthcare Advisor at Arent Fox in Washington, DC, advises medical device, pharmaceutical, diagnostics, biologics and biotech companies in developing and implementing strategies to secure appropriate coverage and value-based reimbursement for novel technologies and mature health care products and services. He helps manufacturers overcome hurdles in the health care reimbursement environment, including evidence planning, payer interaction, coverage, coding, and payment. Mr. Dougherty also works to enhance collaboration between private industry, public research entities and patient advocacy organizations to accelerate the translation of scientific research into effective therapies for the treatment of rare diseases. Before joining Arent Fox, Mr. Dougherty worked as a senior vice president and chair of the health and life sciences practice of a national advisory and advocacy firm. Mr. Dougherty previously directed prospective study design and strategic marketing activities for a Fortune 40 pharmaceutical services company. He led the strategic consulting group within the medical marketing division of a global contract research organization and coordinated outcomes research and reimbursement support activities for a major health care consulting firm. Mr. Dougherty is a frequent speaker at industry conferences on health care policy and reimbursement.
Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing